chrisvoncsefalvay/vaers-outcomes huggingface dataset:
fever; body ache; sore throat; headache; swollen tonsils; ear hurt; difficult to swallow; have fluid on my ears; This is a spontaneous report from a contactable healthcare professional. A 21-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the right arm on an unknown date as a single dose for COVID-19immunisation. Concomitant medications included ivabradine hydrochloride (CORLANOR) ,birth control  for unknown indication on an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration on an unknown date as a single dose for COVID-19immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19.Since the vaccination, the patient had been tested for COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Apr2021 two days after the vaccination the patient experienced  fever, body aches, sore throat, head ache and three days after vaccine she had swollen tonsils, fever, sever body aches, ears hurt. Now 4 days after she have been to the doctor and they said  having a bad viral response to the vaccine, tonsils are swollen and have white spots, temperature is 103, body hurts, hardly swallow anything and  have fluid on her  ears. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the event. On an unknown date, the patient underwent body temperature examination and the result was 103. On 19Apr2021, the patient underwent COVID-19 test (Nasal Swab) and the result was negative.  The clinical outcome of the event fever,  body ache, sore throat, headache, swollen tonsil ,ear hurt and fluid in ear was unknown.   No follow-up attempts are needed. No further information is expected.
Pt recieved #1 dose intradermal, didnt create wheal.  Gave pt 0.4 ML subQ to complete dose. Pt left in no distress
Patient reported she got HPV-9 vaccine on 4/12/2018 Thursday, she had abd pain and vomited x 2 on 4/13/2018 Friday.
1245PM pt recv vax; 1PM pt coughing, crying; 115PM hives, trunk, face, neck; 140PM DPH given
10/16/2021  82yoM with pmh of A Fib (on warfarin), HTN, HFpEF (EF 59%), and psoriasis who presented to the ED due to shortness of breath. He tested positive for COVID on 10/13, the same day as symptom onset. Symptoms included cough productive of rust colored sputum, HA, and feeling "wheezy". He endorses feeling run down and very weak. His work of breathing became more difficult on 10/15 and he felt as though the wheezing was much worse, which prompted him to present to the ED for evaluation. Endorses subjective fevers, chest pain 2/2 coughing, diarrhea, HA, and decreased po intake. Denies nausea, vomiting, or abdominal pain. Is vaccinated against COVID. CXR 10/16: patchy left sided predominant opacities c/w COVID pna  -No oxygen at baseline, now on 2L NC      -SpO2 on RA 93-96%
This spontaneous report was received from a nurse refers to a unspecified patients of unknown age and gender. On an unknown date, the patients were orally vaccinated with improperly stored doses of ROTATEQ (dose, frequency and indication were not reported, lot # K001716 with expiration date: 24-NOV-2015). No adverse event was reported. This is one of the several reports received from the same source. Additional information has been requested.
101.5 fever for 48 hours, but it is the third day after the vaccine, and I still experience : Sore arm, tiredness, weakness, inability to focus, forgetfulness, blurred vision, Exhaustion.  I took Tylenol, Advil, did cold showers, and iced my arm
Approximately 10 minutes following vaccination patient stated she is "itchy." Hives were observed on her neck and chest.  Patient denied shortness of breath, chest pain, or other allergic reactions.  Patient was observed for an additional 15 minutes and advised through medical control that self-monitoring was appropriate. Next day: hives progressed to face and eyes, "puffed out pretty bad." Visited personal doctor and was prescribed prednisone and hydroxyx.
Information has been received from a physician concerning a 16 year old female patient who on 25-MAR-2008 was vaccinated with first dose of GARDASIL (Lot # not reported). On 27-MAY-2008 she received second dose of GARDASIL (Lot # not reported) 0.5ml. After the second dose of vaccine she developed serious allergic reaction. She received third dose of GARDASIL (Lot # not reported) on 28-SEP-2008. The adverse event disappeared after got third dose of vaccine. The patient sought unspecified medical attention. This is one of two reports from the same source. Upon internal review, serious allergic reaction was considered to be an other important medical event. Additional information has been requested.
got vaccine. had rash, pain, itch, numbness in spots / suspected vaccination failure; rash, pain, itch, numbness in spots; rash; pain for nearly 2 months; itch on that side; numbness on that side in spots; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included COVID 19 VACCINE for prophylaxis.   On an unknown date, the patient received Shingles vaccine and the 2nd dose of COVID 19 VACCINE. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, rash, pain, pruritus and numbness. On an unknown date, the outcome of the vaccination failure, shingles, rash, pruritus and numbness were unknown and the outcome of the pain was recovered/resolved.   It was unknown if the reporter considered the vaccination failure, shingles, rash, pain, pruritus and numbness to be related to Shingles vaccine.  Additional case details were reported as follows: The reporter was patient itself. The age at vaccination was not reported. The patient had pain for nearly 2 months and still itch on that side. The patient also had numbness on that side in spots. The patient got about 10 days after his or her second dose of covid vaccine and stated that might not be related to the vaccine. This case was considered as suspected vaccination failure, as details regarding completion of primary vaccination schedule, laboratory test confirmation and time to onset for shingles were unknown at the time of reporting. The follow up was not required.
the 1st dose I became very ill; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (the 1st dose I became very ill) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (the 1st dose I became very ill). At the time of the report, ILLNESS (the 1st dose I became very ill) outcome was unknown.            Reporter did not allow further contact
Mother called stating child had a mild rash and swelling of the glands behind ears, neck and the cheeks. Instructed caregiver to take pt to ER.
Severe shoring pains in head. Muscle and joint pain through out my body. Chills. Fatigue
Soreness at the injection site, pain in arm, currently going on 17 days. Has taken Ibuprofen and Tylenol for soreness.
Extreme irritability, fever 6 days post vaccination. Vomiting started on 02.14.14.
(URI), fever 105F ax, inconsolable crying, "some diarrhea", cough, runny nose.  5/18/07 Received medical records from hospital which reveal patient experienced fever for approx 5 days since receiving vax.  On day of vax, PCP noted reddened right TM but no antibiotics started.  Developed fever & became fussy.  Returned to PCP & started on antibiotics.  Had runny nose, congestion & cough for approx 5 days.  Patient's older brother had cold & OM.Diarrhea x 3 days PTA, vomiting began on day of admit & taken to ER.    LP done was abnormal & admitted 5/2/07-5/5/07 w/meningitis.  Temp in ER was 102.8  Treated w/IV antibiotics & d/c to home on continued oral antibiotics. FINAL DX: meningitis/ss 6/26/07 Received pcp med recs which corrected RO lot #.  VAERS database updated w/same.  Records indicate patient in good health on day of vax.  RTC on 4/30 w/ fever, inconsolable crying & tugging on right ear.  Cold s/s w/cough, nasal congestion & runny nose.  DX w/right otitis media & started on antibiotics.  Records include partial hospital records which reveal patient admitted 5/2-5/5/07 for fever x 5 days, diarrhea x 3 days & vomiting on day of admit.  Sibling recently ill w/cold URI & ear infection.  RTC on 5/7 & was on continued oral antibiotics & doing well w/fluid noted right ear but no redness.  Hospital d/c summary for 10/2-10/6/06 admit for enterovirus meningitis also included. FINAL DX: Aseptic meningitis.
aches; dizziness; swollen a little; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (aches), DIZZINESS (dizziness) and SWELLING (swollen a little) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030MZ0A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 and Bypass surgery. Previously administered products included for an unreported indication: STEROIDS and REMDESIVIR. Concurrent medical conditions included Diabetic.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced PAIN (aches), DIZZINESS (dizziness) and SWELLING (swollen a little). At the time of the report, PAIN (aches), DIZZINESS (dizziness) and SWELLING (swollen a little) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reports being hospitalized with COVID In July of 2020 treated with REMDESIVIR and a STEROID (NOS).  No concomitant medication reported.  No treatment information reported.  Patient reports being hospitalized with COVID In July of 2020 treated with REMDESIVIR and a STEROID (NOS).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 17-Jun-2021: TCR form attached
SUSPECTED CLINICAL VACCINE FAILURE; SUSPECTED COVID-19 INFECTION; This spontaneous report received from a patient concerned a 49 year old male of unknown ethnicity. The patient's weight was 280 pounds, and height was 78 inches. The patient's concurrent conditions included: penicillin allergy, non alcohol user, and non smoker. Consumer was healthy and had no primary care physician. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A and expiry: 23-JUN-2021),dose was not reported,1 total, administered on 03-JUN-2021 for prophylactic vaccination to right arm. No concomitant medications were reported.  On 09-AUG-2021, the patient tested Positive for COVID-19 antigen test and found to have suspected covid-19 infection (suspected clinical vaccine failure). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the suspected covid-19 infection and suspected clinical vaccine failure was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210820111-Covid-19 vaccine ad26.cov2. s-suspected clinical vaccine failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS
weakness, fatigue, full body stiffness, joint and muscle pain and weakness, stiff neck,  difficulty and pain when moving or walking, interrupted sleep due to pain,  unable to lift out of a chair with legs only
About 5 minutes after administering the moderna vaccine, I found the patient lying on the floor face down. She fell from the chair she was seated on, and she was still seated in front of the pharmacy for a 15-minute period of observation. The patient seemed to have lost consciousness for the first few seconds after the fall, however, she was responsive when she was asked how she was feeling. She was aware of her surroundings. The patient stated she did not feel/realize she was falling from the chair, and that she felt dizzy. The fall caused injuries to her face.
Information has been received on 01-MAR-2019 regarding a case in litigation concerning a female  patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. The patient was prescribed ZOSTAVAX by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. On or about 24-MAR-2017, the patient was administered the ZOSTAVAX vaccine (lot# and route not specified) by a pharmacist. The patient was treated by a healthcare provider for shingles as a result of vaccination with ZOSTAVAX. The outcome was not provided. Additional information has been requested.
CONFIRMED COVID-19 INFECTION; CONFIRMED IMMUNOLOGICAL VACCINE FAILURE; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the subject experienced confirmed covid-19 infection, and confirmed immunological vaccine failure. Laboratory data (dates unspecified) included: COVID-19 virus test (NR: not provided) Positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the confirmed covid-19 infection and confirmed immunological vaccine failure was not reported. This report was non-serious.
?Patient received vaccine that was stored improperly. Vaccine was moved from ultra-cold freezer to freezer on 6/17/21. According to guidance from Pfizer, vaccine stored in the freezer after day 17 is considered improperly stored, and the patient will need to be re-vaccinated.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 27-AUG-2015, the patient was vaccinated with a dose of improperly stored MMR II, lot # K024035, expiration date: 26-NOV-2016, (dose, dose number, route of administration and injection site were not reported). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Narrative:  Hospitalization-Admitted for treatment of necrotic toe, fully vaccinated and COVID positive on testing for rehab placement (asymptomatic)
Information has been received from a Registered Nurse concerning a 16 year old female patient who on unspecified dates was vaccinated with all 3 doses of GARDASIL. The patient had a PAP test 2 weeks ago; on approximately 04-JAN-2010 that was "positive high risk in the 30's or 40's for HPV types 16 & 18". The girl had been sexually active for awhile but this was her first PAP test. While she did receive 3 dose of GARDASIL the office had a storage issue with their vaccines and they must revaccinate patients. This patient received one of the GARDASIL vaccine that was not stored properly. The patient's outcome was unknown. The patient sought unspecified medical attention. The nurse reported that there was no additional information about the patient. Additional information has been requested.
Sore arm noted day of vaccine. Following day noted fatigue, dizziness, nausea, chills,  body aches, headache. Most symptoms subsided the next day, headaches and dizziness continue daily one week later.
I got shingles. First I had pain in my right leg and then up my right side. I then developed a fluid-filled blister rash on my leg. I called my doctor at the first sign of the rash and immediately started taking an anti-viral medication 3 times a day. The rash continued to spread, but after a couple of days on the medication, it did not turn into blisters. The pain continued for about 5 weeks and the rash started to disappear over that time.
This spontaneous report as received from a Medical Assistant refers to a 16 year old male patient. The patient's historical condition included anaphylactic reaction to a vaccine component. On 06-AUG-2018 the patient was vaccinated with improperly stored GARDASIL 9 lot # R001262 dose 3 in the left deltoid for prophylaxis (product storage error). The patient did not have any reverse reactions to the vaccine. No adverse events reported.
Dizziness, persistent headaches, muscle weakness, muscle cramps, twitching, tingling, shaking, muscle spasms, blurred vision, double vision, shortness of breath. All of these symptoms have come since my vaccine and haven't gone away. My doctor has been unable to find a cause other than my vaccine
The patients arm was warm to the touch, swollen, and hard. There was also redness to the inside of the arm. The patient was referred to her doctor. Per the patient the doctor told her to take BENADRYL.
pt states has raised area on lt collar bone;sore around collarbone-area 20cm in size;noticed it yesterday afternoon;also swelling noted @ site of inj of Td;states haad bad h/a yesterday;not as bad today
Patient felt a migraine aura that started about 8-10 min post-vaccination.  She was experiencing pain around her left eye and some vision disturbance although no nausea which she stated she usually has.  Patient was still at clinic waiting since it had not been past her 15 min time yet.  We gave her some tylenol and had her move to a room that was a little darker and quieter and kept her for another 30 min (45 min total).  Patient said she still felt like it was the "beginning of a migraine" and not feeling well.  We called someone to come drive her home and sent her home for the rest of the day.
Pt recvd DTP/OPV/MMR/HIB on 17JUN91 & on 24JUN91 fever 106 cont to 26JUN & taken to ER w/105.6 fever given ASA in ER & put on Pediazole for 10 days, dx ear infect & throat infect;
Tinnitus; fatigued; fast heartbeat; slowed breathing on the 2nd and 3rd day; developed a bumpy rash on the elbow of my other arm the next day; instantly had a sore arm; numb fingers/My arm felt dead; felt a heaviness in my chest since the day after and still have that; This is a spontaneous report from a contactable consumer (patient). A 47-years-old non-pregnant female patient received BNT162b2 (Pfizer-BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number and Expiration date was unknown), via an unspecified route of administration administered in left arm on 06Mar2021 at 14:00 hours as dose 1, single (at the age of 22-years-old) for COVID-19 immunisation. Medical history included Gastrooesophageal reflux disease (GERD) and anaemia (both from an unknown date and unknown if ongoing). The patient previously took amoxicillin and experienced allergy to amoxicillin. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient received no other medications/concomitant medications within 2 weeks of vaccination. Patient was not diagnosed with COVID-19, prior to vaccination and had not been tested for COVID-19, since the vaccination. On 06Mar2021 at 15:00 hours, patient instantly had a sore arm and had numb fingers, her arm felt dead. On 07Mar2021 (next day), patient developed a bumpy rash on the elbow of her other arm. On 07Mar2021 (on the 2nd and 3rd day (08Mar2021)), patient was fatigued, had fast heartbeat and slowed breathing. On Mar2021, patient felt a heaviness in her chest since the day after and still had that. On 25Mar2021, the patient experienced tinnitus. Patient received no treatment for the events. The outcome of all the events was not recovered.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
7 days after receiving the shot (1/29/2021) I have a large circular welt/raising of the skin at the injection site. It is painful, itchy, and warm to the touch. Arm appears to be swelling at the site.  As of today (1/30/2021) symptoms are still present, swelling appears to have worsened.
The patient received first dose of RabAvert on 14-Feb-2023 and did not receive second dose since then; Case reference number US-BN-2023-000809 is a spontaneous case report initially received from a pharmacist via Communication (reference number: USBAV23-0622) on 08-May-2023 and concerns a male patient of unknown age.   The patient's relevant medical history and concomitant medication details were not provided.  On 14-Feb-2023, the patient was vaccinated with the first dose of RabAvert (batch number not provided) at an unknown dose, route or site of administration for pre-exposure to rabies. As reported, the patient received the first dose and did not receive the second dose since then (explicitly coded as 'incomplete course of vaccination').    At the time of the initial report, it was unknown if the patient experienced any adverse event due to RabAvert.  Additional information received on 09-May-2023 included local case ID.; Reporter's Comments: A male patient of unknown age was vaccinated with the first dose of RabAvert, at an unknown dose, route or site of administration for pre-exposure to rabies. As reported, the patient received the first dose and did not receive the second dose since then, which is considered as incomplete course of vaccination. It was unknown if the patient experienced any adverse event due to RabAvert. Incomplete course of vaccination is considered as listed per company convention. The patient's relevant medical history and concomitant medication details were not provided. Incomplete course of vaccination has been considered as not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A male patient of unknown age was vaccinated with the first dose of RabAvert, at an unknown dose, route or site of administration for pre-exposure to rabies. As reported, the patient received the first dose and did not receive the second dose since then, which is considered as incomplete course of vaccination. It was unknown if the patient experienced any adverse event due to RabAvert. Incomplete course of vaccination is considered as listed per company convention. The patient's relevant medical history and concomitant medication details were not provided. Incomplete course of vaccination has been considered as not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.